drugset / Trial / NCT01074437

Corticosteroids With Placebo Versus Corticosteroids With Propranolol Treatment of Infantile Hemangiomas (IH)

NCT01074437

Phase 2 Terminated 9 enrolled Seattle Children's Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a prospective randomized, double-blind study to compare the clinical efficacy of infantile hemangioma treatment using propranolol with corticosteroids as compared to therapy with corticosteroids and placebo. We hypothesize that a two-month treatment period with propranolol plus corticosteroids is more effective at reducing infantile hemangioma size and vascularity when compared to corticosteroids used without propranolol for the same time period.

Timeline

Start
2010-02
Primary completion
2012-02
Completion
2013-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Prednisolone Other / unclassified 1 mg/kg Oral
Subject Prednisolone Other / unclassified 2 mg/kg Oral
Subject Propranolol Small molecule 2 mg/kg Oral

Indications